EP4051710
AND-ÆXLIS SAMSETT MEÐFERÐ MEÐ ANTI-CD19 MÓTEFNI OG GAMMA DELTA T-FRUMUM
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
30.10.2020EP published:
26.11.2025EP application number:
20800121.4
EP translation filed:
12.1.2026Grant published:
11.2.2026EPO information:
European Patent Register
Max expiry date:
29.10.2040Expiry date:
29.10.2026
Title in English:
ANTI-TUMOR COMBINATION THERAPY COMPRISING ANTI-CD19 ANTIBODY AND GAMMA DELTA T-CELLSLanguage of the patent:
English
Timeline
Today
30.10.2020EP application
26.11.2025EP Publication
12.1.2026Translation submitted
11.2.2026Registration published
29.10.2026Expires
Owner
Name:
Incyte CorporationAddress:
1801 Augustine Cut-Off, Wilmington, DE 19803, US
Inventor
Name:
ENDELL, JanAddress:
80333 München, DE
Name:
BOXHAMMER, RainerAddress:
83059 Kolbermoor, DE
Name:
PRETSCHER, DominikAddress:
97080 Würzburg, DE
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
19206479Date:
31.10.2019Country:
EP
Classification
Categories:
C07K 16/28, A61K 35/17, A61K 39/395, A61P 35/02, A61K 39/00